Share and Cite: Hinz, B. and Kenyon, J. (2025) Getting to a Diagnosis: A Rare Case of TFE3 Translocation Renal Cell Carcinoma ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

February 6, 2025 MAPK1IP1L::TFE3-rearranged renal cell carcinoma: a novel fusion adding to the differential diagnosis of oncocytic renal neoplasms. February 6, 2025 Multi-institutional Analysis of ...

5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal ... brain metastasis is more common in stage 4 breast cancer patients ...

Clear cell renal cell carcinoma (ccRCC) is the most prevalent and lethal subtype of renal cell carcinoma (RCC), characterized by a poor prognosis and a high likelihood of distant metastasis.

Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80 to 85% of all cases of lung cancer. There are different stages of NSCLC, ranging from 0 to 4; ...

In a significant step forward for India’s cancer treatment, Immuneel Therapeutics, a leading cell and gene therapy statrtup backed by entrepreneur Kiran Mazumdar-Shaw, has unveiled Qartemi, the ...

Treatment for renal cell carcinoma ... particles to destroy cancer cells. It’s rarely used as a primary treatment for kidney cancer, but it’s sometimes recommended if a patient can’t have surgery and ...

Bone pain. Joint pain ... A subgroup of osteosarcoma patients experienced detectable metastasis of their cancer at the time of their diagnosis. This led the team to believe that there is something ...

“Our study demonstrates the critical role of PSMA-PET in accurately staging prostate cancer, which can significantly impact treatment decisions and outcomes,” said Jeremie Calais, MD, PhD.